During the past decade, Johannes Wesling Klinikum Minden conducted 41 clinical trials. In the 10-year time frame, 41 clinical trials started and 13 clinical trials were completed, i.e. on average, 31.7% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 8 clinical trials were completed. i.e. 80% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Johannes Wesling Klinikum Minden" #1 sponsor was "University of Ulm" with 10 trials, followed by "Celgene" with 4 trials sponsored, "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 4 trials sponsored, "Gesellschaft fur Padiatrische Onkologie und Hamatologie - Germany" with 4 trials sponsored and "University Hospital Tuebingen" with 4 trials sponsored. Other sponsors include 60 different institutions and companies that sponsored additional 54 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Johannes Wesling Klinikum Minden" #1 collaborator was "Deutsche Kinderkrebsstiftung" with 3 trials as a collaborator, "Arbeitsgemeinschaft Gynaekologische Onkologie Austria" with 2 trials as a collaborator, "Deutsche Krebshilfe e.V., Bonn (Germany)" with 2 trials as a collaborator, "Hannover Medical School" with 2 trials as a collaborator and "Hoffmann-La Roche" with 2 trials as a collaborator. Other collaborators include 73 different institutions and companies that were collaborators in the rest 82 trials.

According to Clinical.Site data, the most researched conditions in "Johannes Wesling Klinikum Minden" are "Lymphoma" (8 trials), "Primary Myelofibrosis" (6 trials), "Acute Myeloid Leukemia (AML)" (5 trials), "Leukemia" (5 trials) and "Acute Myeloid Leukemia" (4 trials). Many other conditions were trialed in "Johannes Wesling Klinikum Minden" in a lesser frequency.

Most popular intervention types in "Johannes Wesling Klinikum Minden" are "Drug" (70 trials), "Biological" (17 trials), "Radiation" (14 trials), "Procedure" (12 trials) and "Device" (7 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (11 trials), "doxorubicin hydrochloride" (10 trials), "radiation therapy" (10 trials), "vincristine sulfate" (9 trials) and "Placebo" (8 trials). Other intervention names were less common.

The vast majority of trials in "Johannes Wesling Klinikum Minden" are 85 trials for "All" genders and 6 trials for "Female" genders.

Currently, there are NaN active trials in "Johannes Wesling Klinikum Minden". undefined are not yet recruiting, 15 are recruiting, 18 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 43 completed trials in Johannes Wesling Klinikum Minden, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Johannes Wesling Klinikum Minden, 2 "Phase 1" clinical trials were conducted, 23 "Phase 2" clinical trials and 44 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 11 trials that are defined as “Not Applicable".